Compounds > mezlocillin

Page last updated: 2024-08-23

mezlocillin and vancomycin

mezlocillin has been researched along with vancomycin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (50.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	3 (37.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Dover, JS; Kang, S	1
DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR	1
Brooks, GF; Mordenti, J; Ries, C; Tseng, A; Unadkat, N	1
Hall, WC; Hunter, BH; Merritt, J	1
Calderwood, SB; Jackson, E; Tung, CC	1
Brade, V; Hunfeld, KP; Kekoukh, E; Kraiczy, P; Weigand, J; Wichelhaus, TA	1

Other Studies

8 other study(ies) available for mezlocillin and vancomycin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. The British journal of dermatology, 1990, Volume: 123, Issue:3 Topics: Drug Therapy, Combination; Gangrene; Humans; Injections, Intravenous; Male; Mezlocillin; Middle Aged; Pyoderma; Vancomycin	1990
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:6 Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin	1986
Vancomycin-induced neutropenia complicating bone marrow recovery in a patient with leukemia. Case report and review of the literature. The American journal of medicine, 1986, Volume: 80, Issue:2 Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Humans; Infusions, Parenteral; Leukemia, Myeloid; Male; Mezlocillin; Neutropenia; Tobramycin; Vancomycin	1986
Lack of mezlocillin and piperacillin interference in measurement of vancomycin in the Abbott TDx. Clinical chemistry, 1987, Volume: 33, Issue:12 Topics: Drug Interactions; Humans; Mezlocillin; Piperacillin; Vancomycin	1987
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics. Journal of clinical microbiology, 1984, Volume: 19, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin	1984
In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi. International journal of antimicrobial agents, 2001, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Borrelia burgdorferi Group; Drug Resistance, Microbial; Fusidic Acid; Humans; Meropenem; Mezlocillin; Microbial Sensitivity Tests; Monobactams; Penicillins; Ribostamycin; Teicoplanin; Thienamycins; Vancomycin	2001